A member asked:

Are there any promising trials for new ulcerative colitis treatments?

4 doctors weighed in across 2 answers

Trials for colitis: An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

Answered 7/5/2012

5.8k views

Thank

Trials for colitis: An open-label study of vedolizumab (mln0002) in patients with ulcerative colitis and crohn's disease this multicenter, 2-year open-label study will collect data on the occurrence of important clinical safety events resulting from chronic vedolizumab (mln0002) administration.

Answered 3/31/2013

5.8k views

Thank

Related Questions

A member asked:

Treatment for mezalazine-resistant ulcerative colitis?

A doctor has provided 1 answer